The Influence of Autoimmune Diseases on the Baricitinib Market
The rising global prevalence of autoimmune diseases is a primary driver for the robust growth of the Baricitinib Market. Conditions such as rheumatoid arthritis, which affects millions of people worldwide, create a sustained and growing demand for effective, long-term treatments. Baricitinib, by targeting the inflammatory pathways central to these diseases, offers significant relief from...